rs139509075
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_012463.4(ATP6V0A2):c.2384C>T(p.Ala795Val) variant causes a missense change. The variant allele was found at a frequency of 0.000119 in 1,614,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A795T) has been classified as Uncertain significance.
Frequency
Consequence
NM_012463.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP6V0A2 | NM_012463.4 | c.2384C>T | p.Ala795Val | missense_variant | 19/20 | ENST00000330342.8 | |
ATP6V0A2 | XM_024448910.2 | c.2264C>T | p.Ala755Val | missense_variant | 18/19 | ||
ATP6V0A2 | XM_024448911.2 | c.1871C>T | p.Ala624Val | missense_variant | 15/16 | ||
ATP6V0A2 | XM_024448912.2 | c.1562C>T | p.Ala521Val | missense_variant | 12/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP6V0A2 | ENST00000330342.8 | c.2384C>T | p.Ala795Val | missense_variant | 19/20 | 1 | NM_012463.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000414 AC: 63AN: 152196Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000211 AC: 53AN: 251490Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135916
GnomAD4 exome AF: 0.0000876 AC: 128AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.0000784 AC XY: 57AN XY: 727240
GnomAD4 genome ? AF: 0.000420 AC: 64AN: 152314Hom.: 0 Cov.: 31 AF XY: 0.000322 AC XY: 24AN XY: 74486
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 15, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 16, 2017 | - - |
ALG9 congenital disorder of glycosylation Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at